Care Capital

Care Capital is a life sciences venture capital firm based in Princeton, New Jersey. We invest in entrepreneurial companies that are developing pharmaceutical assets and we currently manage approximately $500 million of capital.

Website: www.carecapital.com

Back to List

Lasmiditan

Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT_1F receptors expressed in the trigeminal nerve pathway.

Learn More About Lasmiditan

Media Coverage

Aug 18 2011 CoLucid in Talks with Partners for Novel Migraine Treatment

Press Releases

Sep 9 2011 CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million
Aug 18 2011 CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine